Search Results - "Ayed, Ayed O."

Immunotherapy for multiple myeloma: Current status and future directions by Ayed, Ayed O, Chang, Lung-Ji, Moreb, Jan S

“…Abstract Multiple myeloma (MM) is a plasma cell neoplasm which constitutes about 10% of all hematologic malignancies and has been in the limelight of…”
Get full text

Ruxolitinib as first‐line treatment in secondary hemophagocytic lymphohistiocytosis: A second experience by Zandvakili, Inuk, Conboy, Caitlin B., Ayed, Ayed O., Cathcart‐Rake, Elizabeth J., Tefferi, Ayalew

Get full text

Management of patients with chronic lymphocytic leukemia at high risk of relapse on ibrutinib therapy by Ayed, Ayed O., Parikh, Sameer A.

“…The past two decades have witnessed a paradigm shift in the management of patients with chronic lymphocytic leukemia (CLL), particularly with the introduction…”
Get full text

Interobserver Variability of Mitotic Index and Utility of PHH3 for Risk Stratification in Gastrointestinal Stromal Tumors by Alkhasawneh, Ahmad, Reith, John D., Toro, Tania Zuluaga, Ayed, Ayed O., Lu, Xiaomin, George, Thomas J., Duckworth, Lizette Vila

“…Objectives: Accurate grading of gastrointestinal stromal tumors (GISTs), based on mitotic index, can be problematic. Methods: In this study, we compared…”
Get full text

Results from a Real-World Multicenter Analysis of 482 Patients with Chronic Lymphocytic Leukemia Treated with Ibrutinib: A Look at Racial Differences by Barrientos, Jacqueline C., Ayed, Ayed O., Cha, Agnes, Du, Senxi, Fang, Bruno, Hall, Ryan, Marks, Stanley M., Peng, Eileen, Rhodes, Joanna M., Ryan, Kellie, Winters, Sharon B., Yeung, Percy L., Hou, Jing-Zhou

“…Background Despite recent approvals of lifesaving treatments for chronic lymphocytic leukemia (CLL), real-world data on the tolerability of the Bruton tyrosine…”
Get full text

CNS relapse in patients with DLBCL treated with lenalidomide plus R-CHOP (R2CHOP): analysis from two phase 2 studies by Ayed, Ayed O., Chiappella, Annalisa, Pederson, Levi, Laplant, Betsy R., Congiu, Angela Giovanna, Gaidano, Gianluca, Spina, Michele, Re, Alessandro, Cavallo, Federica, Musuraca, Gerardo, Macon, William R., Witzig, Thomas, Vitolo, Umberto, Nowakowski, Grzegorz S.

“…Central nervous system (CNS) relapse of diffuse large B-cell lymphoma (DLBCL) is a devastating event occurring in ~ 5% of patients treated with R-CHOP. We…”
Get full text

Relationship of serum imatinib trough level and response in CML patients: Long term follow-up by Awidi, Abdalla, Ayed, Ayed O, Bsoul, Nazzal, Magablah, Ahmad, Mefleh, Razan, Dweiri, Mohammad, Ramahi, Mohammad, Arafat, Eyad, Bishtawi, Mohammad, Marie, Lena

“…Abstract One hundred and three patients with Philadelphia chromosome or BCR-ABL positive chronic myeloid leukemia (CML) in chronic phase who were on oral…”
Get full text

Frequency, risk factors, and outcomes of central nervous system relapse in lymphoma patients treated with dose‐adjusted EPOCH plus rituximab by Malecek, Mary‐Kate, Petrich, Adam M., Rozell, Shaina, Chu, Benjamin, Trifilio, Steven, Galanina, Natalie, Maurer, Matthew, Farooq, Umar, Link, Brian K., Nowakowski, Grzegorz S., Nabhan, Chadi, Ayed, Ayed O.

“…Background Central nervous system (CNS) relapse in non‐Hodgkin lymphoma (NHL) is a rare but serious complication that carries a poor prognosis. The use of…”
Get full text

Characteristics of a Comprehensive, Continuously Updated Longitudinal Database for Multiple Myeloma by Blau, C. Anthony, Nam, Grace, Chhun, Leena, Zheng, Cheng, Piboonvaranggoon, Jayne, Wren, Jennifer, Mallick, Elora, Zelko, Lauren, Wolcott, Michiko, Lopez, Carmen, Namburi, Swathi, Blau, Sibel, Senecal, Francis M., McCroskey, Robert, Moezi, Mehdi M., Ayed, Ayed O., Lopez Barquilla, Ricardo, Richter, Joshua, Bensinger, William I., Richardson, Paul G., Anderson, Kenneth C.

“…Introduction: Despite the availability of many effective agents, multiple myeloma is characterized by repeated cycles of treatment response and relapse, and…”
Get full text

Severe Diffuse Alveolar Hemorrhage Associated with Bortezomib Administration in Patients with Multiple Myeloma by Ayed, Ayed O, Moreb, Jan S, Hsu, Jack W., Hiemenz, John W, Wingard, John R, Norkin, Maxim

“…Background: Bortezomib, a proteasome inhibitor, is frequently used in treatment of patients with multiple myeloma (MM). Bortezomib is generally well tolerated…”
Get full text

Lenalidomide Plus R-CHOP (R2CHOP) in Patients with DLBCL Is Associated with a Lower Risk of CNS Relapse: Combined Analysis from Two Phase 2 Studies by Ayed, Ayed O., Chiappella, Annalisa, Nowakowski, Grzegorz S., Cavallo, Federica, Congiu, Angela Giovanna, Gaidano, Gianluca, Pederson, Levi, Laplant, Betsy R., Macon, William R., Musuraca, Gerardo, Re, Alessandro, Spina, Michele, Witzig, Thomas E., Vitolo, Umberto

“…Background Central nervous system (CNS) relapse of diffuse large B-cell lymphoma (DLBCL) is a devastating event occurring in approximately 5% of patients…”
Get full text

Lenalidomide Plus R-CHOP (R2CHOP) in Patients with Follicular Lymphoma: Data from a Phase 1/2 Study by Ayed, Ayed O., Pederson, Levi, Macon, William R., Laplant, Betsy R., Reeder, Craig B., Foran, James M., Nelson, Garth, Rivera, Candido E., Habermann, Thomas M., Witzig, Thomas E., Nowakowski, Grzegorz S.

“…Background Follicular lymphoma (FL) is an indolent non-Hodgkin lymphoma (NHL) with heterogeneous outcomes and remains largely incurable. Immunochemotherapy…”
Get full text

Spark discharge assisted laser induced breakdown spectroscopy by Nassef, O. Ayed, Elsayed-Ali, Hani E.

“…Laser induced breakdown spectroscopy is combined with a spark discharge to operate in a laser triggered spark discharge mode. This spark discharge laser…”
Get full text

Influence of Pyrolysis Environment on Liquid Product and Sulfur of Oil Shale by Al-Ayed, O. S., Matouq, M.

“…Oil shale samples from Ellajun Area were pyrolysed in different pyrolysing environments. Nitrogen, steam, mixture of steam and nitrogen, and mixture of…”
Get full text

Poor Peripheral Blood Stem Cell Mobilization Correlates with Worse Long-Term Outcomes in Multiple Myeloma Patients Undergoing Autologous Stem Cell Transplantation by Moreb, Jan S., MD, Ayed, Ayed O., MD, Byrne, Michael, MD, Shugarman, Ilicia, MD, Yunfeng, Dai, Chang, Myron, PhD, Norkin, Maxim, MD, Hiemenz, John, MD, Brown, Randall, MD, Cogle, Christopher Ramin, MD, May, William S, Wingard, John R., MD, Hsu, Jack W., MD

Get full text

3rd International Oil Shale Conference by Al-Ayed, O

Get full text

Wastewater Treatment Resulting From an Oil Shale Retorting at High Frequency Ultrasound Waves With a Chemical Elemental Analysis by Matouq, M., Al-Ayed, O., Al-Anber, Z., Al-Shannag, M., Kloub, N., Tagawa, T., Aljbour, S.

“…This study aims at applying ultrasound techniques with high frequency to treat wastewater. One application that was chosen here is to apply ultrasound wave on…”
Get full text

Ruxolitinib as first-line treatment in secondary hemophagocytic lymphohistiocytosis: A second experience by Zandvakili, Inuk, Conboy, Caitlin B, Ayed, Ayed O, Cathcart-Rake, Elizabeth J, Tefferi, Ayalew

Get full text

Treated oil shale ash and its capacity to remove Cd and Pb from aqueous solutions by Al-Ayed, Omar, El-Hasan, Tayel, Amro, Abdulaziz, Matouq, Mohammed, Kooli, Fathi

“…Cadmium (Cd) is the most highly toxic heavy metal even at a trace level. In this study, the oil shale ash treated material was used as an adsorbent to remove…”
Get full text

Tracing rare earth elements in oil shale ash by Al-Ayed, Omar S, Qawaqneh, Merania K, Abu-Nameh, Eyad S.M

“…Oil shale ash generated from different locations in Jordan was investigated for rare earth elements (REE). The oil shale samples were combusted at 950…”
Get full text